United States Essential Thrombocythemia Drug Market Report 2018

QYR2451437
97 Pages
February 2018
Pharmaceuticals

Download Sample Get Discount

In this report, the United States Essential Thrombocythemia Drug market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

The West

Southwest

The Middle Atlantic

New England

The South

The Midwest

with sales (volume), revenue (value), market share and growth rate of Essential Thrombocythemia Drug in these regions, from 2013 to 2025 (forecast).

United States Essential Thrombocythemia Drug market competition by top manufacturers/players, with Essential Thrombocythemia Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

AbbVie Inc

Aop Orphan Pharmaceuticals AG

F. Hoffmann-La Roche Ltd

Galena Biopharma Inc

Incyte Corp

Italfarmaco SpA

MEI Pharma Inc

PharmaEssentia Corp

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Givinostat

Idasanutlin

Pracinostat

Ruxolitinib Phosphate

Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

Research Center

Hospital

Clinic

Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

United States Essential Thrombocythemia Drug Market Report 2018

1 Essential Thrombocythemia Drug Overview

1.1 Product Overview and Scope of Essential Thrombocythemia Drug

1.2 Classification of Essential Thrombocythemia Drug by Product Category

1.2.1 United States Essential Thrombocythemia Drug Market Size (Sales Volume) Comparison by Type (2013-2025)

1.2.2 United States Essential Thrombocythemia Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2017

1.2.3 Givinostat

1.2.4 Idasanutlin

1.2.5 Pracinostat

1.2.6 Ruxolitinib Phosphate

1.2.7 Others

1.3 United States Essential Thrombocythemia Drug Market by Application/End Users

1.3.1 United States Essential Thrombocythemia Drug Market Size (Consumption) and Market Share Comparison by Application (2013-2025)

1.3.2 Research Center

1.3.3 Hospital

1.3.4 Clinic

1.3.5 Others

1.4 United States Essential Thrombocythemia Drug Market by Region

1.4.1 United States Essential Thrombocythemia Drug Market Size (Value) Comparison by Region (2013-2025)

1.4.2 The West Essential Thrombocythemia Drug Status and Prospect (2013-2025)

1.4.3 Southwest Essential Thrombocythemia Drug Status and Prospect (2013-2025)

1.4.4 The Middle Atlantic Essential Thrombocythemia Drug Status and Prospect (2013-2025)

1.4.5 New England Essential Thrombocythemia Drug Status and Prospect (2013-2025)

1.4.6 The South Essential Thrombocythemia Drug Status and Prospect (2013-2025)

1.4.7 The Midwest Essential Thrombocythemia Drug Status and Prospect (2013-2025)

1.5 United States Market Size (Value and Volume) of Essential Thrombocythemia Drug (2013-2025)

1.5.1 United States Essential Thrombocythemia Drug Sales and Growth Rate (2013-2025)

1.5.2 United States Essential Thrombocythemia Drug Revenue and Growth Rate (2013-2025)

2 United States Essential Thrombocythemia Drug Market Competition by Players/Suppliers

2.1 United States Essential Thrombocythemia Drug Sales and Market Share of Key Players/Suppliers (2013-2018)

2.2 United States Essential Thrombocythemia Drug Revenue and Share by Players/Suppliers (2013-2018)

2.3 United States Essential Thrombocythemia Drug Average Price by Players/Suppliers (2013-2018)

2.4 United States Essential Thrombocythemia Drug Market Competitive Situation and Trends

2.4.1 United States Essential Thrombocythemia Drug Market Concentration Rate

2.4.2 United States Essential Thrombocythemia Drug Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers Essential Thrombocythemia Drug Manufacturing Base Distribution, Sales Area, Product Type

3 United States Essential Thrombocythemia Drug Sales (Volume) and Revenue (Value) by Region (2013-2018)

3.1 United States Essential Thrombocythemia Drug Sales and Market Share by Region (2013-2018)

3.2 United States Essential Thrombocythemia Drug Revenue and Market Share by Region (2013-2018)

3.3 United States Essential Thrombocythemia Drug Price by Region (2013-2018)

4 United States Essential Thrombocythemia Drug Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)

4.1 United States Essential Thrombocythemia Drug Sales and Market Share by Type (Product Category) (2013-2018)

4.2 United States Essential Thrombocythemia Drug Revenue and Market Share by Type (2013-2018)

4.3 United States Essential Thrombocythemia Drug Price by Type (2013-2018)

4.4 United States Essential Thrombocythemia Drug Sales Growth Rate by Type (2013-2018)

5 United States Essential Thrombocythemia Drug Sales (Volume) by Application (2013-2018)

5.1 United States Essential Thrombocythemia Drug Sales and Market Share by Application (2013-2018)

5.2 United States Essential Thrombocythemia Drug Sales Growth Rate by Application (2013-2018)

5.3 Market Drivers and Opportunities

6 United States Essential Thrombocythemia Drug Players/Suppliers Profiles and Sales Data

6.1 AbbVie Inc

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Essential Thrombocythemia Drug Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 AbbVie Inc Essential Thrombocythemia Drug Sales, Revenue, Price and Gross Margin (2013-2018)

6.1.4 Main Business/Business Overview

6.2 Aop Orphan Pharmaceuticals AG

6.2.2 Essential Thrombocythemia Drug Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Aop Orphan Pharmaceuticals AG Essential Thrombocythemia Drug Sales, Revenue, Price and Gross Margin (2013-2018)

6.2.4 Main Business/Business Overview

6.3 F. Hoffmann-La Roche Ltd

6.3.2 Essential Thrombocythemia Drug Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 F. Hoffmann-La Roche Ltd Essential Thrombocythemia Drug Sales, Revenue, Price and Gross Margin (2013-2018)

6.3.4 Main Business/Business Overview

6.4 Galena Biopharma Inc

6.4.2 Essential Thrombocythemia Drug Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Galena Biopharma Inc Essential Thrombocythemia Drug Sales, Revenue, Price and Gross Margin (2013-2018)

6.4.4 Main Business/Business Overview

6.5 Incyte Corp

6.5.2 Essential Thrombocythemia Drug Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Incyte Corp Essential Thrombocythemia Drug Sales, Revenue, Price and Gross Margin (2013-2018)

6.5.4 Main Business/Business Overview

6.6 Italfarmaco SpA

6.6.2 Essential Thrombocythemia Drug Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Italfarmaco SpA Essential Thrombocythemia Drug Sales, Revenue, Price and Gross Margin (2013-2018)

6.6.4 Main Business/Business Overview

6.7 MEI Pharma Inc

6.7.2 Essential Thrombocythemia Drug Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 MEI Pharma Inc Essential Thrombocythemia Drug Sales, Revenue, Price and Gross Margin (2013-2018)

6.7.4 Main Business/Business Overview

6.8 PharmaEssentia Corp

6.8.2 Essential Thrombocythemia Drug Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 PharmaEssentia Corp Essential Thrombocythemia Drug Sales, Revenue, Price and Gross Margin (2013-2018)

6.8.4 Main Business/Business Overview

7 Essential Thrombocythemia Drug Manufacturing Cost Analysis

7.1 Essential Thrombocythemia Drug Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Essential Thrombocythemia Drug

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Essential Thrombocythemia Drug Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Essential Thrombocythemia Drug Major Manufacturers in 2017

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Essential Thrombocythemia Drug Market Size (Value and Volume) Forecast (2018-2025)

11.1 United States Essential Thrombocythemia Drug Sales Volume, Revenue Forecast (2018-2025)

11.2 United States Essential Thrombocythemia Drug Sales Volume Forecast by Type (2018-2025)

11.3 United States Essential Thrombocythemia Drug Sales Volume Forecast by Application (2018-2025)

11.4 United States Essential Thrombocythemia Drug Sales Volume Forecast by Region (2018-2025)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Essential Thrombocythemia Drug

Figure United States Essential Thrombocythemia Drug Market Size (K Pcs) by Type (2013-2025)

Figure United States Essential Thrombocythemia Drug Sales Volume Market Share by Type (Product Category) in 2017

Figure Givinostat Product Picture

Figure Idasanutlin Product Picture

Figure Pracinostat Product Picture

Figure Ruxolitinib Phosphate Product Picture

Figure Others Product Picture

Figure United States Essential Thrombocythemia Drug Market Size (K Pcs) by Application (2013-2025)

Figure United States Sales Market Share of Essential Thrombocythemia Drug by Application in 2017

Figure Research Center Examples

Table Key Downstream Customer in Research Center

Figure Hospital Examples

Table Key Downstream Customer in Hospital

Figure Clinic Examples

Table Key Downstream Customer in Clinic

Figure Others Examples

Table Key Downstream Customer in Others

Figure United States Essential Thrombocythemia Drug Market Size (Million USD) by Region (2013-2025)

Figure The West Essential Thrombocythemia Drug Revenue (Million USD) and Growth Rate (2013-2025)

Figure Southwest Essential Thrombocythemia Drug Revenue (Million USD) and Growth Rate (2013-2025)

Figure The Middle Atlantic Essential Thrombocythemia Drug Revenue (Million USD) and Growth Rate (2013-2025)

Figure New England Essential Thrombocythemia Drug Revenue (Million USD) and Growth Rate (2013-2025)

Figure The South of US Essential Thrombocythemia Drug Revenue (Million USD) and Growth Rate (2013-2025)

Figure The Midwest Essential Thrombocythemia Drug Revenue (Million USD) and Growth Rate (2013-2025)

Figure United States Essential Thrombocythemia Drug Sales (K Pcs) and Growth Rate (2013-2025)

Figure United States Essential Thrombocythemia Drug Revenue (Million USD) and Growth Rate (2013-2025)

Figure United States Essential Thrombocythemia Drug Market Major Players Product Sales Volume (K Pcs) (2013-2018)

Table United States Essential Thrombocythemia Drug Sales (K Pcs) of Key Players/Suppliers (2013-2018)

Table United States Essential Thrombocythemia Drug Sales Share by Players/Suppliers (2013-2018)

Figure 2017 United States Essential Thrombocythemia Drug Sales Share by Players/Suppliers

Figure United States Essential Thrombocythemia Drug Market Major Players Product Revenue (Million USD) (2013-2018)

Table United States Essential Thrombocythemia Drug Revenue (Million USD) by Players/Suppliers (2013-2018)

Table United States Essential Thrombocythemia Drug Revenue Share by Players/Suppliers (2013-2018)

Figure 2017 United States Essential Thrombocythemia Drug Revenue Share by Players/Suppliers

Table United States Market Essential Thrombocythemia Drug Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018)

Figure United States Market Essential Thrombocythemia Drug Average Price (USD/Pcs) of Key Players/Suppliers in 2017

Figure United States Essential Thrombocythemia Drug Market Share of Top 3 Players/Suppliers

Figure United States Essential Thrombocythemia Drug Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers Essential Thrombocythemia Drug Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers Essential Thrombocythemia Drug Product Category

Table United States Essential Thrombocythemia Drug Sales (K Pcs) by Region (2013-2018)

Table United States Essential Thrombocythemia Drug Sales Share by Region (2013-2018)

Figure United States Essential Thrombocythemia Drug Sales Share by Region (2013-2018)

Figure United States Essential Thrombocythemia Drug Sales Market Share by Region in 2017

Table United States Essential Thrombocythemia Drug Revenue (Million USD) and Market Share by Region (2013-2018)

Table United States Essential Thrombocythemia Drug Revenue Share by Region (2013-2018)

Figure United States Essential Thrombocythemia Drug Revenue Market Share by Region (2013-2018)

Figure United States Essential Thrombocythemia Drug Revenue Market Share by Region in 2017

Table United States Essential Thrombocythemia Drug Price (USD/Pcs) by Region (2013-2018)

Table United States Essential Thrombocythemia Drug Sales (K Pcs) by Type (2013-2018)

Table United States Essential Thrombocythemia Drug Sales Share by Type (2013-2018)

Figure United States Essential Thrombocythemia Drug Sales Share by Type (2013-2018)

Figure United States Essential Thrombocythemia Drug Sales Market Share by Type in 2017

Table United States Essential Thrombocythemia Drug Revenue (Million USD) and Market Share by Type (2013-2018)

Table United States Essential Thrombocythemia Drug Revenue Share by Type (2013-2018)

Figure Revenue Market Share of Essential Thrombocythemia Drug by Type (2013-2018)

Figure Revenue Market Share of Essential Thrombocythemia Drug by Type in 2017

Table United States Essential Thrombocythemia Drug Price (USD/Pcs) by Types (2013-2018)

Figure United States Essential Thrombocythemia Drug Sales Growth Rate by Type (2013-2018)

Table United States Essential Thrombocythemia Drug Sales (K Pcs) by Application (2013-2018)

Table United States Essential Thrombocythemia Drug Sales Market Share by Application (2013-2018)

Figure United States Essential Thrombocythemia Drug Sales Market Share by Application (2013-2018)

Figure United States Essential Thrombocythemia Drug Sales Market Share by Application in 2017

Table United States Essential Thrombocythemia Drug Sales Growth Rate by Application (2013-2018)

Figure United States Essential Thrombocythemia Drug Sales Growth Rate by Application (2013-2018)

Table AbbVie Inc Basic Information List

Table AbbVie Inc Essential Thrombocythemia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure AbbVie Inc Essential Thrombocythemia Drug Sales Growth Rate (2013-2018)

Figure AbbVie Inc Essential Thrombocythemia Drug Sales Market Share in United States (2013-2018)

Figure AbbVie Inc Essential Thrombocythemia Drug Revenue Market Share in United States (2013-2018)

Table Aop Orphan Pharmaceuticals AG Basic Information List

Table Aop Orphan Pharmaceuticals AG Essential Thrombocythemia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure Aop Orphan Pharmaceuticals AG Essential Thrombocythemia Drug Sales Growth Rate (2013-2018)

Figure Aop Orphan Pharmaceuticals AG Essential Thrombocythemia Drug Sales Market Share in United States (2013-2018)

Figure Aop Orphan Pharmaceuticals AG Essential Thrombocythemia Drug Revenue Market Share in United States (2013-2018)

Table F. Hoffmann-La Roche Ltd Basic Information List

Table F. Hoffmann-La Roche Ltd Essential Thrombocythemia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure F. Hoffmann-La Roche Ltd Essential Thrombocythemia Drug Sales Growth Rate (2013-2018)

Figure F. Hoffmann-La Roche Ltd Essential Thrombocythemia Drug Sales Market Share in United States (2013-2018)

Figure F. Hoffmann-La Roche Ltd Essential Thrombocythemia Drug Revenue Market Share in United States (2013-2018)

Table Galena Biopharma Inc Basic Information List

Table Galena Biopharma Inc Essential Thrombocythemia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure Galena Biopharma Inc Essential Thrombocythemia Drug Sales Growth Rate (2013-2018)

Figure Galena Biopharma Inc Essential Thrombocythemia Drug Sales Market Share in United States (2013-2018)

Figure Galena Biopharma Inc Essential Thrombocythemia Drug Revenue Market Share in United States (2013-2018)

Table Incyte Corp Basic Information List

Table Incyte Corp Essential Thrombocythemia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure Incyte Corp Essential Thrombocythemia Drug Sales Growth Rate (2013-2018)

Figure Incyte Corp Essential Thrombocythemia Drug Sales Market Share in United States (2013-2018)

Figure Incyte Corp Essential Thrombocythemia Drug Revenue Market Share in United States (2013-2018)

Table Italfarmaco SpA Basic Information List

Table Italfarmaco SpA Essential Thrombocythemia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure Italfarmaco SpA Essential Thrombocythemia Drug Sales Growth Rate (2013-2018)

Figure Italfarmaco SpA Essential Thrombocythemia Drug Sales Market Share in United States (2013-2018)

Figure Italfarmaco SpA Essential Thrombocythemia Drug Revenue Market Share in United States (2013-2018)

Table MEI Pharma Inc Basic Information List

Table MEI Pharma Inc Essential Thrombocythemia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure MEI Pharma Inc Essential Thrombocythemia Drug Sales Growth Rate (2013-2018)

Figure MEI Pharma Inc Essential Thrombocythemia Drug Sales Market Share in United States (2013-2018)

Figure MEI Pharma Inc Essential Thrombocythemia Drug Revenue Market Share in United States (2013-2018)

Table PharmaEssentia Corp Basic Information List

Table PharmaEssentia Corp Essential Thrombocythemia Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure PharmaEssentia Corp Essential Thrombocythemia Drug Sales Growth Rate (2013-2018)

Figure PharmaEssentia Corp Essential Thrombocythemia Drug Sales Market Share in United States (2013-2018)

Figure PharmaEssentia Corp Essential Thrombocythemia Drug Revenue Market Share in United States (2013-2018)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Essential Thrombocythemia Drug

Figure Manufacturing Process Analysis of Essential Thrombocythemia Drug

Figure Essential Thrombocythemia Drug Industrial Chain Analysis

Table Raw Materials Sources of Essential Thrombocythemia Drug Major Players/Suppliers in 2017

Table Major Buyers of Essential Thrombocythemia Drug

Table Distributors/Traders List

Figure United States Essential Thrombocythemia Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)

Figure United States Essential Thrombocythemia Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Figure United States Essential Thrombocythemia Drug Price (USD/Pcs) Trend Forecast (2018-2025)

Table United States Essential Thrombocythemia Drug Sales Volume (K Pcs) Forecast by Type (2018-2025)

Figure United States Essential Thrombocythemia Drug Sales Volume (K Pcs) Forecast by Type (2018-2025)

Figure United States Essential Thrombocythemia Drug Sales Volume (K Pcs) Forecast by Type in 2025

Table United States Essential Thrombocythemia Drug Sales Volume (K Pcs) Forecast by Application (2018-2025)

Figure United States Essential Thrombocythemia Drug Sales Volume (K Pcs) Forecast by Application (2018-2025)

Figure United States Essential Thrombocythemia Drug Sales Volume (K Pcs) Forecast by Application in 2025

Table United States Essential Thrombocythemia Drug Sales Volume (K Pcs) Forecast by Region (2018-2025)

Table United States Essential Thrombocythemia Drug Sales Volume Share Forecast by Region (2018-2025)

Figure United States Essential Thrombocythemia Drug Sales Volume Share Forecast by Region (2018-2025)

Figure United States Essential Thrombocythemia Drug Sales Volume Share Forecast by Region in 2025

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

Publish Date: November 14, 2017
$5370

View Details

Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

Publish Date: July 20, 2017
$5370

View Details

Global Orphan Drugs Market by Disease Type (Oncologic Diseases, Metabolic Diseases, Hematologic and Immunologic Diseases, Infectious Diseases, Neurologic Diseases and Other Rare Diseases), Indication (Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Cystic Fibrosis, Glioma, Pancreatic Cancer, Ovarian Cancer, Multiple Myeloma, Duchenne Muscular Dystrophy, Graft vs Host Disease, Renal Cell Carcinoma and Others) - Global Opportunity Analysis and Industry Forecast, 2014-2022

The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...

Publish Date: April 24, 2017
$5370

View Details

Client Testimonials

Your team has worked hard to help and to provide our research needs to fulfill our significant initiatives...

Maria

-Researcher

The report on EAA resins was detailed and informative. However, we were hopeful to discover a Chinese producer ...

David

-President Protech Oxyplast Group

Thanks the attached report is perfect and accurate, but I was wondering if you can show the price trend in one year...

United States Essential Thrombocythemia Drug Market Report 2018

Contact Us

Drop Us an email at

Similar Reports

Client Testimonials

Maria

David

Sara